Joseph is a Junior analyst at SOSV; one of the worlds most active early stage investors. SOSV has various investment vehicles and Joseph is primarily working within SOSV’s RebelBio accelerator. Prior to working at SOSV, Joseph undertook a Masters in Finance and Private Equity at the London School of Economics, whilst working for GP Bullhound’s Venture Capital division. Joseph is very passionate about solving public health issues and improving the world we live in.

Joseph will be moderating the debate on December 4th titled “Agnostic or Pure players in the biotech sector: who is becoming prominent in the early-stage financing rounds”.